4//SEC Filing
Eizen Joshua M 4
Accession 0001193125-25-270255
CIK 0001880438other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 6:12 PM ET
Size
5.5 KB
Accession
0001193125-25-270255
Insider Transaction Report
Form 4
Eizen Joshua M
See Remarks
Transactions
- Sale
Common Stock
2025-11-04$1.14/sh−2,819$3,214→ 177,353 total
Footnotes (3)
- [F1]Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on November 4, 2025.
- [F2]Includes, in accordance with the original terms, (a) 31,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024 (b) 22,500 RSUs which vest as follows: 1/3rd of the RSUs vest annually over three years from January 1, 2025 and (c) 45,000 RSUs which vest as follows: 2/3rd of the RSUs vest on January 1, 2026 and 1/3rd of the RSUs vest on July 1, 2026, subject to the Reporting Person's continuous service as of such date.
- [F3]Reflects the adjusted total which includes the purchase of 5,000 shares under the Issuer's 2022 Employee Stock Purchase Plan on September 30, 2025.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001949621
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 6:12 PM ET
- Size
- 5.5 KB